insights_auto
Why is 524494 down 3,51%?
Dive Deeperchevron_right
524494:BOM
IPCA Laboratories Ltd
1 845,00 ₹
arrow_downward
-3,51%(-67,20) 1D
16 հոկ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524494...
Open
1 913,95 ₹
High
1 913,95 ₹
Low
1 812,60 ₹
Mkt. cap
468,21 մլրդ
Avg. vol.
27,90 հզր
Volume
12,00 հզր
Dividend
0,33%
Quarterly dividend
1,50 ₹
Ex-dividend date
07 օգս, 2026 թ.
P/E ratio
35,74
52-wk high
2 039,30 ₹
52-wk low
1 252,95 ₹
EPS
51,63 ₹
Shares outstanding
126,35 մլն
No. of employees
17 հզր
Open
1 913,95 ₹
High
1 913,95 ₹
Low
1 812,60 ₹
Mkt. cap
468,21 մլրդ
Avg. vol.
27,90 հզր
Volume
12,00 հզր
Dividend
0,33%
Quarterly dividend
1,50 ₹
Ex-dividend date
07 օգս, 2026 թ.
P/E ratio
35,74
52-wk high
2 039,30 ₹
52-wk low
1 252,95 ₹
EPS
51,63 ₹
Shares outstanding
126,35 մլն
No. of employees
17 հզր
News stories
From web sources and news partners
GlobeNewswire
·
51 րոպե առաջ
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Business Wire
·
1 ժամ առաջ
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
marketscreener.com
·
16 րոպե առաջ
CECO Environmental Corp. Primary Exchange Listing will Change to Texas Stock Exchange from Nasdaq Global Select
Bloomberg.com
·
2 ժամ առաջ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
About IPCA Laboratories Ltd